OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
An Open Debate on the Morphological Measurement Methodologies of the Infrapatellar Fat Pad to Determine Its Association with the Osteoarthritis Process	109
Decoding the Intricacies of Statin-Associated Muscle Symptoms	105
Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS	45
Role of IFN-α in Rheumatoid Arthritis	42
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout	42
Axial Spondyloarthritis Clinical Research Year in Review: SPARTAN 2024 Annual Meeting Proceedings	38
Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?	37
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease	37
Correction to: Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?	36
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature	36
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis	35
Updates on Clinical Trials in Systemic Lupus Erythematosus	31
Novel Therapies for ANCA-associated Vasculitis	28
Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus	27
Intersections Between Mitochondrial Metabolism and Redox Biology Mediate Posttraumatic Osteoarthritis	27
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	27
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	26
Enzymatic Machinery of Ubiquitin and Ubiquitin-Like Modification Systems in Chondrocyte Homeostasis and Osteoarthritis	26
Engineering Closed-Loop, Autoregulatory Gene Circuits for Osteoarthritis Cell-Based Therapies	26
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response	25
Cannabis for Rheumatic Disease Pain: a Review of Current Literature	25
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes	24
Trabecular Bone Score in Rheumatic Disease	24
Emerging Concepts in Precision Medicine in Axial Spondyloarthritis	22
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis	22

Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine S	21
Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings	21
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature	21
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review	21
Pipeline Therapies for Gout	21
Updating the 2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (SPARTAN 2024 Annual Meeting Proceedings)	20
Advancements in Imaging Techniques for Early Diagnosis and Management of Axial Spondyloarthritis	19
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis	18
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms	18
Non-Pharmacological Pain Management of Rheumatoid Arthritis	18
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria	18
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	18
Epidemiology of Antiphospholipid Syndrome in the General Population	17
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology	17
Mesangial Cells in Lupus Nephritis	17
An Update on the Diagnosis and Management of Calcium Crystal Disease	17
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	17
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist	16
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome	16
Update on Uric Acid and the Kidney	15
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis	15
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments	15
Has the COVID 19 Pandemic Impacted the Management of Chronic Musculoskeletal Pain?	15
An Update on Multi-System Inflammatory Syndrome in Children	14
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	14
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?	14
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?	13
Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis	13
Treatment of Reactive Arthritis with Biological Agents	12
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention	12
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?	12
T Cell Dysregulation in Rheumatoid Arthritis: from Genetic Susceptibility to Established Disease	12
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies	12
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know	12
Newer Autoantibodies and Laboratory Assessments in Myositis	12
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia	12
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review	12
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients’ Outcomes	11
Deep Insight into the Role of MIF in Spondyloarthritis	11
Calcinosis in Juvenile Dermatomyositis—Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review	11
Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment	10
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis	10
Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis	10
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings	10
The Use of COVID-19 Vaccines in Patients with SLE	10
Possible Role of Dysbiosis of the Gut Microbiome in SLE	10
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions	10
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022	10
AA Amyloidosis: A Contemporary View	10
Temperature-Mediated Neural Interventions in Knee Osteoarthritis: a Review of Cryoneurolysis and Cooled Radiofrequency Ablation with Ultrasound Guidance	9

Localized Forms of Vasculitis	9
Precision Medicine in Rheumatology: The Promise of Ultrasound-Guided Synovial Biopsy, Barriers to Its Implementation in the United States, and Proposed Solutions	9
Erosive Hand Osteoarthritis: Recent Advances and Future Treatments	8
Current perspective on infections and mitigation strategies in primary systemic vasculitis	8
Review: The Role of Dual-Energy Computed Tomography in Detecting Monosodium Urate Deposits in Vascular Tissues	8
What Has Dual Energy CT Taught Us About Gout?	7
Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)	7
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?	7
Understanding Spondyloarthritis Pathogenesis: The Promise of Single-Cell Profiling	7
Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond	7
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	7
Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings)	6
Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review	6
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy	6
Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene	6
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review	6
The Role of Podocytes in Lupus Pathology	6
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement	6
Unconventional Imaging Methods in Psoriatic Arthritis	6
The Role of Antiphospholipid Antibodies in COVID-19	6
Chondrocalcinosis: Advances in Diagnostic Imaging	6
Updates in diagnosis and treatment of pediatric antiphospholipid syndrome	6
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies	6
The Interplay of Biomechanical and Biological Changes Following Meniscus Injury	6
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus	6
Anatomical Joint Form Variation in Sacroiliac Joint Disease: Current Concepts and New Perspectives	6
A Spotlight on Drug-Induced Vasculitis	6